跳至主要内容
临床试验/NCT04220450
NCT04220450Unknown不适用

T1-mapping by Cardiovascular Magnetic Resonance Imaging to Assess Non-Alcoholic Fatty Liver Disease

Dr. Andreas Kammerlander1 个研究点 分布在 1 个国家目标入组 800 人开始时间: 2020年6月1日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
800
试验地点
1
主要终点
Correlation NAFLD and liver T1mapping

研究概览

简要总结

On clinically indicated Cardiovascular Magnetic Resonance studies, native T1-times and extracellular volume of the liver will be assessed and findings correlated with established risk calculators for non-alcoholic fatty liver disease.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Cross Sectional

入排标准

年龄范围
18 Months 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Referred for Cardiovascular Magnetic Resonance Imaging

排除标准

  • Non-compatible Devices

结局指标

主要结局

Correlation NAFLD and liver T1mapping

时间窗: cross-sectional within one year

Correlation NAFLD risk score and liver T1-mapping (native and ECV9

次要结局

未报告次要终点

研究者

发起方
Dr. Andreas Kammerlander
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Andreas Kammerlander

Principal Investigator

Medical University of Vienna

研究点 (1)

Loading locations...

相似试验